| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 704556 | Null | 0.0462077035966084 | 0.56270206 |
| NSC 707465 | 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- | 0.0462077035966084 | 0.51599847 |
| NSC 709100 | Null | 0.0462077035966084 | 0.49451132 |
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.0462077035966084 | 0.38245865 |
| NSC 728040 | 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline | 0.0462077035966084 | 0.49182104 |
| NSC 728132 | 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3,4-dichlorobenzene | 0.0462077035966084 | 0.2979656 |
| NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.0462077035966084 | 0.2945549 |
| NSC 736081 | 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine | 0.0462077035966084 | 0.40496536 |
| NSC 736153 | Null | 0.0462077035966084 | 0.40564854 |
| NSC 743244 | Null | 0.0462077035966084 | 0.42026457 |